18 results were returned
A new Infectious Diseases Act (the "Act") came into force on 1 March 2017 in Finland. As a new obligation, Section 48 of the Act stipulates that specific employees and interns in the health care sector must have ...
The worldwide COVID-19 pandemic has led to a scramble for pharmaceutical and medical devices which can prevent or treat COVID-19 infections. Currently there is no vaccine or treatment for COVID-19 ...
The European Commission just published guidelines on the restrictions of the free movement principles in the context of the current COVID-19 crisis. Based on overriding public security and public health grounds, many ...
On 14 March 2020, the Spanish Government formally declared the "state of alarm", which implies amongst other measures the limitation of citizens' circulation rights and general closure of retail commerce.
International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")
International law firm Bird & Bird advises Mitsubishi Chemical Advanced Materials (MCAM), a leading global manufacturer of high-performance materials and a business division of Mitsubishi Chemical Corporation, Japan, on ...
In the wake of the current (and second) #metoo wave which has also hit Danish companies, this is a good opportunity for companies to update their company and/or employee handbook on sexual harassment to ensure that ...
On 9 July 2020, the Employment (Amendment) Bill 2019 (the "Bill") was passed by the Hong Kong Legislative Council.
We have advised Aphria Deutschland GmbH on its tender for the cultivation, processing and delivery of cannabis for medical purposes.
In the last six months, the Hungarian Data Protection Authority (“NAIH”) has imposed a total of approx. EUR 5,000 in data protection fines for the private use of corporate email accounts, in three cases.